查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750858

伴侶動物藥品市場規模、佔有率、趨勢分析報告：依產品、動物、適應症、通路、地區、細分市場預測，2025-2034

Companion Animal Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Animal, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2034
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

伴侶動物藥品市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球伴侶動物藥物市場規模預計到2034年將達到669.6億美元，2025年至2034年期間的複合年成長率為11.14%。

推動伴侶動物藥物市場成長的關鍵因素是寵物數量的增加、疾病盛行率的上升以及寵物保險的普及。

例如在加拿大，根據加拿大動物健康研究所（CAHI）的數據，到2022年，全國超過一半的家庭（約60%）將擁有至少一隻狗或一隻貓。狗的數量將從2020年的770萬隻增加到2022年的790萬隻，貓的數量將從2020年的810萬隻增加到2022年的850萬隻。 CAHI也報告稱，2020年新冠疫情爆發後，貓的獸醫就診次數急劇增加。

新冠疫情對伴侶動物藥品市場造成了顯著影響，包括銷售額下降、供應鏈挑戰、營運困難、住院人數減少以及需求下降。例如，禮來公司（Elanco）報告稱，2020年第二季營收下降了20%。伴侶動物部門尤其受到國際市場品牌認知度下降以及疫苗等臨床用藥銷售量下降的負面影響。

該公司報告稱，2020年下半年銷售額有所回升。同時，Vetoquinol報告稱，儘管獸醫診所和診所的可及性有限，但由於其包含動物用藥品在內的重要產品組合，2020年的銷售額仍實現成長。勃林格殷格翰的伴侶動物業務也實現了銷售成長。

隨著全球寵物數量的成長，寵物人性化趨勢在多個關鍵市場日益興起。寵物主人越來越關注寵物的健康、治療和福祉。因此，越來越多的人選擇購買寵物保險，以降低寵物的財務風險。 Petplan 是英國最大的寵物保險公司，為各種寵物提供保險，包括狗、貓、馬、小型哺乳動物、鳥類、爬蟲類、兔子以及多寵物家庭。這些保險涵蓋醫療和線上諮詢、處方藥、診斷測試、手術、牙科損傷、癌症治療等。

寵物疾病盛行率的上升也是預期推動市場成長的主要因素。例如，寵物通常會感染由體內和體外寄生蟲引起的寄生蟲感染疾病。對於膿皮病，醫生通常會開抗生素和局部治療。然而，對於慢性或復發性膿皮病，醫生也可能建議進一步檢查並定期使用藥用洗髮精洗澡。例如，Vivaldis 的 Viv Silky 洗髮精適用於治療各種真菌和細菌感染疾病，包括表淺和深層膿皮病。

伴侶動物藥物市場報告重點

  • 2024 年，藥品部門佔了最大的市場佔有率，為 59.53%。伴侶動物藥物部門包括用於治療多種健康狀況的各種產品。
  • 由於寵物飼養的普及、獸醫保健支出的增加以及針對犬類疾病的藥物供應的增加，伴侶動物藥物行業的狗類藥物部分正在經歷強勁成長。
  • 2024 年，感染疾病領域佔據了全球伴侶動物藥物市場的主導地位，這得益於傳染病負擔的加重以及對預防性醫療保健的日益重視。
  • 根據分銷管道，到 2024 年，醫院藥房部門將佔據市場主導地位。造成這一巨大佔有率的因素包括醫院患者數量的增加，以及寵物確診後立即購買所需藥品的便利性。
  • 2024 年，北美地區將佔據市場主導地位，佔據最大的收益佔有率，超過 36.04%，這得益於該地區人均動物保健支出高且寵物飼主數量眾多。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 北美伴侶動物藥物市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
    • 產業分析-波特五力分析
    • PESTEL分析
  • 按產品進行價格分析
  • 法律規範
  • 產品平臺分析
  • COVID-19影響分析
  • 主要物種疾病盛行率估計分析

第4章。全球伴侶動物藥品市場：按產品的估計和趨勢分析

  • 細分儀表板
  • 全球伴侶動物藥品市場：基於產品的趨勢分析（2024 年和 2034 年）
    • 生物製藥
    • 製藥
    • 藥用飼料添加劑

第5章全球伴侶動物藥品市場：按物種的估計和趨勢分析

  • 細分儀表板
  • 全球伴侶動物藥品市場：2024 年和 2034 年物種差異分析
    • 狗
    • 貓
    • 馬
    • 其他動物

第6章。全球伴侶動物藥物市場：按適應症的估計和趨勢分析

  • 細分儀表板
  • 全球伴侶動物藥物市場：2024 年和 2034 年按適應症分類的趨勢分析
    • 感染疾病
    • 皮膚病
    • 疼痛
    • 整形外科疾病
    • 行為障礙
    • 其他適應症

第7章全球伴侶動物藥品市場：按分銷管道進行的估計和趨勢分析

  • 細分儀表板
  • 全球伴侶動物藥品市場：2024 年和 2034 年通路變化分析
    • 零售
    • 電子商務
    • 醫院/診所藥房

8. 全球伴侶動物藥品市場：區域估計與趨勢分析

  • 2024 年及 2034 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • 市場規模、預測趨勢分析，2018 年至 2034 年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 參與企業分類
  • 企業市場分析/熱圖分析
  • 公司簡介
    • Merck &Co., Inc.
    • Ceva
    • Vetoquinol
    • Zoetis
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • Ourofino Animal Health
    • Virbac
    • Phibro Animal Health Corporation
    • Dechra Pharmaceuticals Plc
    • Bimeda Inc.
  • 戰略地圖
    • 合併與收購
    • 夥伴關係和合作
    • 擴張
    • 產品發布
    • 其他
  • 其他主要參與者名單
Product Code: GVR-4-68039-698-0

Companion Animal Medicine Market Growth & Trends:

The global companion animal medicine market size is expected to reach USD 66.96 billion by 2034 and is expected to expand at 11.14% CAGR from 2025 to 2034, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market for companion animal medicine include the rising pet population, the increased prevalence of diseases, and the availability of pet insurance.

In Canada for example, more than half of the country's households (around 60% of households) owned at least one dog or cat in 2022, according to the Canadian Animal Health Institute (CAHI). The country's dog population increased from 7.7 million in 2020 to 7.9 million in 2022, whereas the cat population increased from 8.1 million in 2020 to 8.5 million in 2022. CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020.

The COVID-19 pandemic notably affected the market for companion animal medicine. The impact included dampened sales, supply chain challenges, operational hurdles, falling inpatient visits, and reduced demand. Elanco for instance reported a 20% decline in revenue during Q2 2020. The company's companion animal segment, in particular, was adversely impacted by the fall in brands in international markets and those administered in the clinic e.g. vaccines.

The company reported a recovery in sales during H2 2020. Vetoquinol on the other hand reported an increase in sales, driven by its essential portfolio including veterinary drugs in 2020 despite limited access to vet clinics and hospitals due to lockdown protocols. Boehringer Ingelheim too registered increased sales in the companion animal segment.

With the rising number of pets across the globe, the trend of pet humanization has gained traction in several key markets. Pet guardians are becoming increasingly aware of their pet's health, treatment, and well-being. This has increased the adoption of pet insurance to reduce the financial risks for them. Petplan- the largest pet insurance provider in the U.K. offers insurance policies for various species including dogs, cats, horses, small mammals, birds, reptiles, rabbits, and multi-pet owners. These policies provide coverage for physical and online consultations, prescription medicine, diagnostic tests, surgery, dental injury, cancer treatment, and more.

The rising prevalence of diseases in pets is another key driver expected to contribute to market growth. Parasitic infections from internal and external parasites for example, commonly affect pets. Antibiotics and topical therapies are often prescribed in the case of pyoderma. However, further testing and routine bathing with medicated shampoos may be prescribed in case of chronic or recurring pyoderma. For example, Viv Silky Shampoo by Vivaldis is indicated for various fungal and bacterial infections including superficial and deep pyoderma.

Companion Animal Medicine Market Report Highlights:

  • The pharmaceuticals segment held the largest market share of 59.53% in 2024. The pharmaceuticals segment for companion animals includes various products to treat multiple health conditions.
  • The dog segment within the companion animal medicine industry is experiencing robust growth, driven by widespread pet ownership, increasing veterinary healthcare spending, and the growing availability of medicines designed for canine conditions.
  • The infectious diseases segment dominated the global companion animal medicine in 2024, driven by the growing burden of transmissible diseases and heightened focus on preventive care.
  • The hospital pharmacy segment dominated the market by distribution channel in 2024. The factors contributing to the large share include higher patient footfalls at hospitals and the convenience of buying the necessary medications as soon as the pet is diagnosed
  • North America region dominated the market in 2024 and registered the largest revenue share of over 36.04%. This is due to the region's high per capita animal healthcare spending and a large number of pet owners

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definition
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
  • 1.6. Market Formulation & Visualization
  • 1.7. Data Validation & Publishing
  • 1.8. Model Details
    • 1.8.1. Commodity flow analysis
    • 1.8.2. Global Market: CAGR Calculation
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Companion Animal Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rapid Advancements in the Field of Companion Animal Medicine
      • 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets
      • 3.2.1.3. Support Initiatives
      • 3.2.1.4. Changing Pet Demographics Globally
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Emergence of Adverse Drug Reactions (ADR)
      • 3.2.2.2. Complex Regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis - Porter's
      • 3.2.5.1. Bargaining power of the suppliers
      • 3.2.5.2. Bargaining power of the buyers
      • 3.2.5.3. Threats of substitution
      • 3.2.5.4. Threats from new entrants
      • 3.2.5.5. Competitive rivalry
    • 3.2.6. PESTEL Analysis
      • 3.2.6.1. Political landscape
      • 3.2.6.2. Economic and Social landscape
      • 3.2.6.3. Technological landscape
  • 3.3. Pricing Analysis, by Product
  • 3.4. Regulatory framework
  • 3.5. Product Pipeline Analysis
  • 3.6. COVID-19 Impact Analysis
  • 3.7. Estimated Disease Prevalence Analysis by Key Species

Chapter 4. Global Companion Animal Medicine Market: By Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Companion Animal Medicine Market: By Product Movement Analysis, 2024 & 2034 (USD Million)
    • 4.2.1. Biologics
      • 4.2.1.1. Biologics Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.2. Vaccines
        • 4.2.1.2.1. Vaccines Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.2.2. Modified/ Attenuated Live
          • 4.2.1.2.2.1. Modified/ Attenuated Live Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.2.3. Inactivated (Killed)
          • 4.2.1.2.3.1. Inactivated (Killed) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.2.4. Other Vaccines
          • 4.2.1.2.4.1. Other Vaccines Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.3. Other Biologics
        • 4.2.1.3.1. Other Biologics Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.3.2. Monoclonal Antibody (mAb)
          • 4.2.1.3.2.1. Monoclonal Antibody (mAb) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
          • 4.2.1.3.2.2. Dogs
            • 4.2.1.3.2.2.1. Dogs Market Estimates And Forecasts, 2018 - 2034 (USD Million)
          • 4.2.1.3.2.3. Cats
            • 4.2.1.3.2.3.1. Cats Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.3.3. Other Biologics (excluding mAb)
          • 4.2.1.3.3.1. Other Biologics (excluding mAb) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.2. Pharmaceuticals
      • 4.2.2.1. Pharmaceuticals Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.2.2. Parasiticides
        • 4.2.2.2.1. Parasiticides Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.2.3. Anti-infectives
        • 4.2.2.3.1. Anti-infectives Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.2.4. Anti-inflammatory
        • 4.2.2.4.1. Anti-inflammatory Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.2.5. Other Pharmaceuticals
        • 4.2.2.5.1. Other Pharmaceuticals Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.3. Medicated Feed Additives
      • 4.2.3.1. Medicated Feed Additives Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 5. Global Companion Animal Medicine Market: By Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Companion Animal Medicine Market: By Animal Movement Analysis, 2024 & 2034 (USD Million)
    • 5.2.1. Dogs
      • 5.2.1.1. Dogs Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 5.2.2. Cats
      • 5.2.2.1. Cats Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 5.2.3. Horses
      • 5.2.3.1. Horses Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 5.2.4. Other Animals
      • 5.2.4.1. Other Animals Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 6. Global Companion Animal Medicine Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Companion Animal Medicine Market: By Indication Movement Analysis, 2024 & 2034 (USD Million)
    • 6.2.1. Infectious Diseases
      • 6.2.1.1. Infectious Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 6.2.2. Dermatologic Diseases
      • 6.2.2.1. Dermatologic Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 6.2.3. Pain
      • 6.2.3.1. Pain Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 6.2.4. Orthopedic Diseases
      • 6.2.4.1. Orthopedic Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 6.2.5. Behavioral Diseases
      • 6.2.5.1. Behavioral Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 6.2.6. Other Indications
      • 6.2.6.1. Other Indications Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 7. Global Companion Animal Medicine Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Companion Animal Medicine Market: By Distribution Channel Movement Analysis, 2024 & 2034 (USD Million)
    • 7.2.1. Retail
      • 7.2.1.1. Retail Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 7.2.2. E-commerce
      • 7.2.2.1. E-commerce Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 7.2.3. Hospital/ Clinic Pharmacy
      • 7.2.3.1. Hospital/ Clinic Pharmacy Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 8. Global Companion Animal Medicine Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2034
  • 8.2. Regional Market Dashboard
  • 8.3. Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2034:
  • 8.5. North America
    • 8.5.1. North America market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. U.S. market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Canada market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Mexico market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.2. UK
      • 8.6.2.1. UK market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Germany market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. France market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Italy market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.6. Spain
      • 8.6.6.1. Spain market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.7. Norway
      • 8.6.7.1. Norway market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.8. Sweden
      • 8.6.8.1. Sweden market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.6.9. Denmark
      • 8.6.9.1. Denmark market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.2. Japan
      • 8.7.2.1. Japan market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. China market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. India market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.5. Australia
      • 8.7.5.1. Australia market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.6. South Korea
      • 8.7.6.1. South Korea market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Thailand market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.8.2. Brazil
      • 8.8.2.1. Brazil market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Argentina market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. South Africa market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Saudi Arabia market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. UAE market estimates and forecasts 2018 to 2034 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Kuwait market estimates and forecasts 2018 to 2034 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profile
    • 9.3.1. Merck & Co., Inc.
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Ceva
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Vetoquinol
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Zoetis
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Boehringer Ingelheim International GmbH
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Elanco Animal Health Incorporated
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Ourofino Animal Health
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Virbac
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Phibro Animal Health Corporation
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Dechra Pharmaceuticals Plc
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Bimeda Inc.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Expansion
    • 9.4.4. Product launch
    • 9.4.5. Others
  • 9.5. List of other Key players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 4. Global Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 5. Global Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 6. Global Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 7. Global Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 8. Global Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 9. Global Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 10. Global Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 11. Global Companion Animal Medicine Market, by Region, 2018 - 2034 (USD Million)
  • Table 12. North America Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
  • Table 13. North America Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 14. North America Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 15. North America Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 16. North America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 17. North America Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 18. North America Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 19. North America Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 20. North America Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 21. U.S. Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 22. U.S. Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 23. U.S. Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 24. U.S. Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 25. Canada Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 26. Canada Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 27. Canada Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 28. Canada Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 29. Canada Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 30. Canada Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 31. Canada Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 32. Canada Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 33. Mexico Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 34. Mexico Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 35. Mexico Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 36. Mexico Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 37. Mexico Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 38. Mexico Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 39. Mexico Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 40. Mexico Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 41. Europe Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
  • Table 42. Europe Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 43. Europe Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 44. Europe Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 45. Europe Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 46. Europe Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 47. Europe Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 48. Europe Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 49. Europe Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 50. Germany Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 51. Germany Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 52. Germany Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 53. Germany Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 54. Germany Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 55. Germany Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 56. Germany Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 57. Germany Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 58. UK Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 59. UK Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 60. UK Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 61. UK Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 62. UK Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 63. UK Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 64. UK Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 65. UK Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 66. France Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 67. France Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 68. France Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 69. France Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 70. France Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 71. France Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 72. France Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 73. France Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 74. Italy Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 75. Italy Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 76. Italy Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 77. Italy Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 78. Italy Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 79. Italy Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 80. Italy Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 81. Italy Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 82. Spain Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 83. Spain Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 84. Spain Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 85. Spain Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 86. Spain Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 87. Spain Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 88. Spain Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 89. Spain Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 90. Denmark Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 91. Denmark Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 92. Denmark Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 93. Denmark Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 94. Denmark Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 95. Denmark Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 96. Denmark Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 97. Denmark Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 98. Sweden Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 99. Sweden Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 100. Sweden Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 101. Sweden Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 102. Sweden Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 103. Sweden Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 104. Sweden Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 105. Sweden Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 106. Norway Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 107. Norway Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 108. Norway Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 109. Norway Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 110. Norway Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 111. Norway Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 112. Norway Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 113. Norway Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 114. Asia Pacific Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
  • Table 115. Asia Pacific Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 116. Asia Pacific Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 117. Asia Pacific Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 118. Asia Pacific Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 119. Asia Pacific Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 120. Asia Pacific Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 121. Asia Pacific Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 122. Asia Pacific Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 123. China Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 124. China Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 125. China Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 126. China Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 127. China Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 128. China Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 129. China Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 130. China Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 131. Japan Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 132. Japan Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 133. Japan Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 134. Japan Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 135. Japan Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 136. Japan Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 137. Japan Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 138. Japan Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 139. India Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 140. India Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 141. India Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 142. India Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 143. India Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 144. India Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 145. India Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 146. India Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 147. South Korea Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 148. South Korea Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 149. South Korea Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 150. South Korea Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 151. South Korea Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 152. South Korea Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 153. South Korea Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 154. South Korea Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 155. Australia Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 156. Australia Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 157. Australia Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 158. Australia Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 159. Australia Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 160. Australia Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 161. Australia Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 162. Australia Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 163. Thailand Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 164. Thailand Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 165. Thailand Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 166. Thailand Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 167. Thailand Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 168. Thailand Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 169. Thailand Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 170. Thailand Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 171. Latin America Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
  • Table 172. Latin America Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 173. Latin America Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 174. Latin America Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 175. Latin America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 176. Latin America Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 177. Latin America Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 178. Latin America Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 179. Latin America Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 180. Brazil Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 181. Brazil Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 182. Brazil Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 183. Brazil Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 184. Brazil Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 185. Brazil Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 186. Brazil Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 187. Brazil Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 188. Argentina Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 189. Argentina Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 190. Argentina Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 191. Argentina Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 192. Argentina Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 193. Argentina Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 194. Argentina Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 195. Argentina Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 196. Middle East & Africa Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
  • Table 197. Middle East & Africa Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 198. Middle East & Africa Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 199. Middle East & Africa Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 200. Middle East & Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 201. Middle East & Africa Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 202. Middle East & Africa Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 203. Middle East & Africa Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 204. Middle East & Africa Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 205. South Africa Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 206. South Africa Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 207. South Africa Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 208. South Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 209. South Africa Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 210. South Africa Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 211. South Africa Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 212. South Africa Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 213. Saudi Arabia Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 214. Saudi ArabiaCompanion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 215. Saudi ArabiaCompanion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 216. Saudi ArabiaCompanion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 217. Saudi ArabiaCompanion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 218. Saudi Arabia Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 219. Saudi Arabia Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 220. Saudi Arabia Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 221. UAE Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 222. UAE Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 223. UAE Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 224. UAE Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 225. UAE Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 226. UAE Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 227. UAE Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 228. UAE Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 229. Kuwait Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
  • Table 230. Kuwait Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
  • Table 231. Kuwait Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
  • Table 232. Kuwait Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Table 233. Kuwait Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
  • Table 234. Kuwait Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
  • Table 235. Kuwait Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
  • Table 236. Kuwait Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
  • Table 237. Company Overview
  • Table 238. Product Benchmarking
  • Table 239. Financial Performance
  • Table 240. Strategic Initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Companion Animal Medicine Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Companion Animal Medicine Market, for Product, 2018 - 2034 (USD Million)
  • Fig. 15 Global Companion Animal Medicine Market, for Biologics, 2018 - 2034 (USD Million)
  • Fig. 16 Global Companion Animal Medicine Market, for Vaccines, 2018 - 2034 (USD Million)
  • Fig. 17 Global Companion Animal Medicine Market, for Modified/ Attenuated Live, 2018 - 2034 (USD Million)
  • Fig. 18 Global Companion Animal Medicine Market, for Inactivated (Killed), 2018 - 2034 (USD Million)
  • Fig. 19 Global Companion Animal Medicine Market, for Other Vaccines, 2018 - 2034 (USD Million)
  • Fig. 20 Global Companion Animal Medicine Market, for Other Biologics, 2018 - 2034 (USD Million)
  • Fig. 21 Global Companion Animal Medicine Market, for Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
  • Fig. 22 Global Companion Animal Medicine Market, for Dogs, 2018 - 2034 (USD Million)
  • Fig. 23 Global Companion Animal Medicine Market, for Cats, 2018 - 2034 (USD Million)
  • Fig. 24 Global Companion Animal Medicine Market, for Other Biologics (excluding mAb), 2018 - 2034 (USD Million)
  • Fig. 25 Global Companion Animal Medicine Market, for Pharmaceuticals, 2018 - 2034 (USD Million)
  • Fig. 26 Global Companion Animal Medicine Market, for Parasiticides, 2018 - 2034 (USD Million)
  • Fig. 27 Global Companion Animal Medicine Market, for Anti-infectives, 2018 - 2034 (USD Million)
  • Fig. 28 Global Companion Animal Medicine Market, for Anti-inflammatory, 2018 - 2034 (USD Million)
  • Fig. 29 Global Companion Animal Medicine Market, for Analgesics, 2018 - 2034 (USD Million)
  • Fig. 30 Global Companion Animal Medicine Market, for Other Pharmaceuticals, 2018 - 2034 (USD Million)
  • Fig. 31 Global Companion Animal Medicine Market, for Medicated Feed Additives, 2018 - 2034 (USD Million)
  • Fig. 32 Global Companion Animal Medicine Market, for Animal, 2018 - 2034 (USD Million)
  • Fig. 33 Global Companion Animal Medicine Market, for Dogs, 2018 - 2034 (USD Million)
  • Fig. 34 Global Companion Animal Medicine Market, for Cats 2018 - 2034 (USD Million)
  • Fig. 35 Global Companion Animal Medicine Market, for Horses 2018 - 2034 (USD Million)
  • Fig. 36 Global Companion Animal Medicine Market, for Other Animals 2018 - 2034 (USD Million)
  • Fig. 37 Global Companion Animal Medicine Market, for Indication 2018 - 2034 (USD Million)
  • Fig. 38 Global Companion Animal Medicine Market, for Infectious Diseases 2018 - 2034 (USD Million)
  • Fig. 39 Global Companion Animal Medicine Market, for Dermatologic Diseases 2018 - 2034 (USD Million)
  • Fig. 40 Global Companion Animal Medicine Market, for Pain 2018 - 2034 (USD Million)
  • Fig. 41 Global Companion Animal Medicine Market, for Orthopedic Diseases 2018 - 2034 (USD Million)
  • Fig. 42 Global Companion Animal Medicine Market, for Behavioral Diseases 2018 - 2034 (USD Million)
  • Fig. 43 Global Companion Animal Medicine Market, for Other Indications 2018 - 2034 (USD Million)
  • Fig. 44 Global Companion Animal Medicine Market, for Distribution Channel 2018 - 2034 (USD Million)
  • Fig. 45 Global Companion Animal Medicine Market, for Retail 2018 - 2034 (USD Million)
  • Fig. 46 Global Companion Animal Medicine Market, for E-commerce 2018 - 2034 (USD Million)
  • Fig. 47 Global Companion Animal Medicine Market, for Hospitals/Clinics 2018 - 2034 (USD Million)
  • Fig. 48 Regional Outlook, 2024 & 2034
  • Fig. 49 North America Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 50 U.S. Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 51 Canada Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 52 Mexico Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 53 Europe Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 54 Germany Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 55 UK Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 56 France Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 57 Italy Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 58 Spain Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 59 Denmark Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 60 Sweden Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 61 Norway Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 62 Asia Pacific Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 63 Japan Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 64 China Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 65 India Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 66 Australia Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 67 South Korea Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 68 Thailand Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 69 Latin America Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 70 Brazil Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 71 Argentina Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 72 Middle East and Africa Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 73 South Africa Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 74 Saudi Arabia Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 75 UAE Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 76 Kuwait Companion Animal Medicine Market, 2018 - 2034 (USD Million)
  • Fig. 77 Heat map analysis